BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 38426560)

  • 1. Insights into the Molecular Mechanisms of Genetic Predisposition to Hematopoietic Malignancies: The Importance of Gene-Environment Interactions.
    Cobaleda C; Godley LA; Nichols KE; Wlodarski MW; Sanchez-Garcia I
    Cancer Discov; 2024 Mar; 14(3):396-405. PubMed ID: 38426560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inherited thrombocytopenia and platelet disorders with germline predisposition to myeloid neoplasia.
    Galera P; Dulau-Florea A; Calvo KR
    Int J Lab Hematol; 2019 May; 41 Suppl 1():131-141. PubMed ID: 31069978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Germline Predisposition to Myeloid Neoplasms: Diagnostic Concepts and Classifications.
    Obiorah IE; Upadhyaya KD; Calvo KR
    Clin Lab Med; 2023 Dec; 43(4):615-638. PubMed ID: 37865507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Times, They Are A-Changing: The Impact of Next-Generation Sequencing on Diagnosis, Classification, and Prognostication of Myeloid Malignancies With Focus on Myelodysplastic Syndrome, AML, and Germline Predisposition.
    Gurbuxani S; Hochman MJ; DeZern AE; Shimamura A
    Am Soc Clin Oncol Educ Book; 2023 Jun; 43():e390026. PubMed ID: 37307513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Germline mutations in MDS/AML predisposition disorders.
    Godley LA
    Curr Opin Hematol; 2021 Mar; 28(2):86-93. PubMed ID: 33394724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Germline predisposition to hematopoietic malignancies.
    Feurstein S; Drazer M; Godley LA
    Hum Mol Genet; 2021 Oct; 30(20):R225-R235. PubMed ID: 34100074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer predisposition syndromes associated with myeloid malignancy.
    Quinn E; Nichols KE
    Semin Hematol; 2017 Apr; 54(2):115-122. PubMed ID: 28637615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Germline CHEK2 and ATM Variants in Myeloid and Other Hematopoietic Malignancies.
    Stubbins RJ; Korotev S; Godley LA
    Curr Hematol Malig Rep; 2022 Aug; 17(4):94-104. PubMed ID: 35674998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial Acute Myeloid Leukemia and Myelodysplasia in Hungary.
    Király AP; Kállay K; Gángó A; Kellner Á; Egyed M; Szőke A; Kiss R; Vályi-Nagy I; Csomor J; Matolcsy A; Bödör C
    Pathol Oncol Res; 2018 Jan; 24(1):83-88. PubMed ID: 28357685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Universal genetic testing for inherited susceptibility in children and adults with myelodysplastic syndrome and acute myeloid leukemia: are we there yet?
    Tawana K; Drazer MW; Churpek JE
    Leukemia; 2018 Jul; 32(7):1482-1492. PubMed ID: 29483711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic Predisposition to Myelodysplastic Syndrome in Clinical Practice.
    Schratz KE; DeZern AE
    Hematol Oncol Clin North Am; 2020 Apr; 34(2):333-356. PubMed ID: 32089214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Approach Toward Germline Predisposition Syndromes in Patients with Hematologic Malignancies.
    Atluri H; Gerstein YS; DiNardo CD
    Curr Hematol Malig Rep; 2022 Dec; 17(6):275-285. PubMed ID: 36279069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in germline predisposition to acute leukaemias and myeloid neoplasms.
    Klco JM; Mullighan CG
    Nat Rev Cancer; 2021 Feb; 21(2):122-137. PubMed ID: 33328584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The International Consensus Classification (ICC) of hematologic neoplasms with germline predisposition, pediatric myelodysplastic syndrome, and juvenile myelomonocytic leukemia.
    Rudelius M; Weinberg OK; Niemeyer CM; Shimamura A; Calvo KR
    Virchows Arch; 2023 Jan; 482(1):113-130. PubMed ID: 36445482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Genetic predisposition to myelodysplastic syndrome/leukemia].
    Hirabayashi S
    Rinsho Ketsueki; 2021; 62(8):1029-1037. PubMed ID: 34497189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying patients with genetic predisposition to acute myeloid leukemia.
    Obrochta E; Godley LA
    Best Pract Res Clin Haematol; 2018 Dec; 31(4):373-378. PubMed ID: 30466750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hematological Malignancies in Adults With a Family Predisposition.
    Bochtler T; Haag GM; Schott S; Kloor M; Krämer A; Müller-Tidow C
    Dtsch Arztebl Int; 2018 Dec; 115(50):848-854. PubMed ID: 30722840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical and genomic landscape of patients with DDX41 variants identified during diagnostic sequencing.
    Maierhofer A; Mehta N; Chisholm RA; Hutter S; Baer C; Nadarajah N; Pohlkamp C; Thompson ER; James PA; Kern W; Haferlach C; Meggendorfer M; Haferlach T; Blombery P
    Blood Adv; 2023 Dec; 7(23):7346-7357. PubMed ID: 37874914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pedigree investigation, clinical characteristics, and prognosis analysis of haematological disease patients with germline TET2 mutation.
    Wu X; Deng J; Zhang N; Liu X; Zheng X; Yan T; Ye W; Gong Y
    BMC Cancer; 2022 Mar; 22(1):262. PubMed ID: 35279121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Genetic predisposition to pediatric myeloid malignancies].
    Muramatsu H
    Rinsho Ketsueki; 2016 Jun; 57(6):730-5. PubMed ID: 27384852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.